Literature DB >> 24309631

[Treatment of severe recurrent symblepharopterygium: combined ipsilateral autologous limbus and homologous amniotic membrane transplantation].

C Huchzermeyer1, Z Gatzioufas, F E Kruse, B Seitz.   

Abstract

BACKGROUND: This retrospective study reports on four patients with severe recurrent symblepharopterygium formation and extensive subconjunctival scarring who were treated with a novel surgical technique combining free limbal autografting and amniotic membrane transplantation. PATIENTS AND METHODS: The surgical technique included symblepharolysis, meticulous removal of subconjunctival scar tissue, ipsilateral free limbal autograft and homologous amniotic membrane transplantation.
RESULTS: There were no intraoperative or postoperative adverse events and three patients had no manifestation of recurrence of pterygium, symblepharon or diplopia during a mean follow-up period of 172 ± 18 weeks (39 ± 4 months) postoperatively. Only one patient had persistent symblepharon and experienced a recurrence of pterygium approximately 40 weeks (9 months) after surgery.
CONCLUSION: The results suggest that ipsilateral autologous limbal and homologous amniotic membrane transplantation can be an effective therapeutic approach in the treatment of recurrent pterygium with symblepharon formation.

Entities:  

Mesh:

Year:  2014        PMID: 24309631     DOI: 10.1007/s00347-013-2979-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  21 in total

Review 1.  The treatment of pterygium.

Authors:  Lawrence W Hirst
Journal:  Surv Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 6.048

2.  Conjunctival-limbal autograft, amniotic membrane transplantation, and intraoperative mitomycin C for primary pterygium.

Authors:  Ugur Keklikci; Yusuf Celik; Sevin Soker Cakmak; M Kaan Unlu; Bagdagul Bilek
Journal:  Ann Ophthalmol (Skokie)       Date:  2007

Review 3.  Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.

Authors:  Stephen C Kaufman; Deborah S Jacobs; W Barry Lee; Sophie X Deng; Mark I Rosenblatt; Roni M Shtein
Journal:  Ophthalmology       Date:  2012-10-11       Impact factor: 12.079

4.  Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.

Authors:  P Prabhasawat; K Barton; G Burkett; S C Tseng
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

5.  [Impact of pterygium size on corneal topography and visual acuity - a prospective clinical cross-sectional study].

Authors:  B Seitz; A Gütay; M Küchle; M M Kus; A Langenbucher
Journal:  Klin Monbl Augenheilkd       Date:  2001-09       Impact factor: 0.700

6.  Pterygium and ultraviolet radiation: a positive correlation.

Authors:  D J Moran; F C Hollows
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

7.  Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.

Authors:  Ahmad Kheirkhah; Hassan Hashemi; Mohsen Adelpour; Mojgan Nikdel; Mohammad Bagher Rajabi; Mahmoud Jabbarvand Behrouz
Journal:  Ophthalmology       Date:  2011-12-06       Impact factor: 12.079

8.  Cryopreserved human amniotic membrane for ocular surface reconstruction.

Authors:  F E Kruse; A M Joussen; K Rohrschneider; L You; B Sinn; J Baumann; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-01       Impact factor: 3.117

9.  The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft.

Authors:  Napaporn Tananuvat; Tada Martin
Journal:  Cornea       Date:  2004-07       Impact factor: 2.651

10.  Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium.

Authors:  Jun Shimazaki; Koichi Kosaka; Shigeto Shimmura; Kazuo Tsubota
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

View more
  1 in total

1.  [Double vision in a 60-year-old male patient].

Authors:  Amine Maamri; Shady Suffo; Barbara Käsmann-Kellner; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-06-10       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.